GB2241705A - Preparing glucans - Google Patents
Preparing glucans Download PDFInfo
- Publication number
- GB2241705A GB2241705A GB9005051A GB9005051A GB2241705A GB 2241705 A GB2241705 A GB 2241705A GB 9005051 A GB9005051 A GB 9005051A GB 9005051 A GB9005051 A GB 9005051A GB 2241705 A GB2241705 A GB 2241705A
- Authority
- GB
- United Kingdom
- Prior art keywords
- strain
- cyclosophoran
- eps
- producing
- cyclosophorans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001503 Glucan Polymers 0.000 title abstract description 7
- 150000004676 glycans Chemical class 0.000 claims abstract description 7
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 7
- 239000005017 polysaccharide Substances 0.000 claims abstract description 7
- 241000589158 Agrobacterium Species 0.000 claims abstract description 6
- 241000589180 Rhizobium Species 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 244000005700 microbiome Species 0.000 claims abstract 4
- 238000000034 method Methods 0.000 claims description 9
- 241000589194 Rhizobium leguminosarum Species 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000589126 Rhizobium phaseoli Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241000589196 Sinorhizobium meliloti Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- -1 alditol acetates Chemical class 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000011968 cross flow microfiltration Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/41—Rhizobium
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A process for preparing a cyclosophoran (a cyclic glucan) comprises cultivating a suitable mutant strain of a microorganism that has been prepared by introducing a transposon into the parent strain, the parent strain being capable of producing both cyclosophoran and extracellular polysaccharide while the mutant strain is incapable of producing extracellular polysaccharide (EPS). The parent stratin may be any suitable strain that produces EPS and cyclosophorans, e.g. of Agrobacterium or Rhizobium.
Description
PREPARING GLUCANS
This invention relates to a process for preparing glucans and, in particular, cyclosophorans.
Cyclosophorans are cyclic ss(1+2)D glucans secreted by several strains of Agrobacterium and Rhizobium.
Xanthomonas bacteria can produce an unusual branched cyclosophoran. The culture fluids normally contain cyclosophorans of varying molecular weight, or degree of polymerisation (dp). Typical values lie in the range dp = 17 - 24. The distribution of dp values has been found to be characteristic of the particular bacterial strain of Agrobacterium or Rhizobium, as reported by
Koizumi et al, J. Chromatography 299 (198t) 21'.-2.zA, Ut 218.
These cyclic compounds are of interest for at least two reasons. Firstly, genetic mutants of Rhizobium meliloti which are unable to export cyclosophorans do not fix nitrogen in their plant host. Cyclic glucans may therefore play an essential role in the plant-bacterium symbiosis. Secondly, there is evidence that cyclosophorans may reserMle, and perhaps surpass, cyclodextrins in their complex-forming properties.
Cyclosophorans are normally secreted into the culture medium together with large amounts of highly viscous extracellular polysaccharide (EPS). The EPS may itself be of importance, and has been the subject of investigation. Production of the highly viscous EPS l 1keE aeration and agitation of the culture broth di-ficu31, nd slso hinders removal of bacterial cells from the broth. Separation of the cyclosophorans requires fractionation with alcohol followed by column chromatographic separation using ion-exchange and
Sephadex resins. These procedures are time-consuming and wasteful in the use of solvents.
Higashuira et al, Agric. Biol. Chem. 49 (1985) 1865, have described the production and isolation of cyclosophorans from EPS mutants of R. leguminosarum bv.
phaseoli AHU133, obtained by chemical mutagenesis.
EP-A-0106311 and EP-A-0108355 describe processes for preparing cyclosophorans by cultivation of a strain of
Agrobacterium or Rhizobium phaseoli, respectively, which does not produce EPS. Such EPS strains were obtained by conventional mutagenic techniques.
Known EPS mutants can produce reasonable levels of cyclosophorans without EPS. However, their stability is limited.
According to a first aspect of the present invention, a cyclosophoran is prepared by cultivation of a suitable EPS strain that has been prepared by introducing a transposon into the parent EPS-producing strain. The resulting strain is relatively stable.
According to a second aspect of the present invention, a cyclosophoran is prepared by cultivation of a strain of Rhizobium leguminosarum having the characteristics of the strain that was deposited on 22nd
February 1990 at the National Collection of Industrial and Marine Bacteria and having the accession number NCIMB 40260.
The parent strain is any suitable strain producing
EPS and cyclosophorans, e.g. of Agrobacterium or
Rhizobium. An EPS mutant is derived from the parent strain by introducing a transposon, by methods generally known per se. Whereas if point mutation occurs (a single base change on DNA), this can revert. By the transposon technique, however, a deletion occurs (i.e. some DNA is lost), this is not easily repaired and so is stable.
For example, by subjecting the parent strain to suitable conditions in the presence of a transposon, preferably a transposon having a characteristic marker such as kanamycin-resistance, stable EPS mutants can be readily obtained by simple screening of relatively few colonies by comparison with the covnentional mutagenic procedures previously described, e.g. chemical or by irradiation The introduction of transposon involves mixing, on plates, the wild-type parent strain with, say,
E. coli containing a plasmid in which the transposon resides. The whole of the plasmid then mates into the parent strain and selection is carried out.
Once obtained, the EPS mutant can be cultivated under conditions known per se, in a suitable nutrient medium, e.g. under conditions described in the prior art described above. Depending on the cultivated strain, the cyclosophoran or, usually, mixture of cyclosophorans that is produced can be used, say, as a complexing agent, to give inclusion complexes of cyclosophorans with, for example, steroids, prostaglandins, ubiquinone, vitamins, indomethacins, amphotericin B or aspartame. Inclusion complexes can be used for the purposes of, for example, solubilisation, stabilisation, catalysis, separation, chiral resolution and slow release.
The following Example illustrates the invention.
Example
The deposited EPS mutant R. leguminosarum was grown in shake flask culture, at pH 6.8 and 290C, in the following medium:
Component g/l
Sodium glutamate 22.4
Mannitol 80.0
MgSO4.7H2O 1.25 CaCl2. 6H2O 0,22 K2HPO4 1.25 FeCl3. 6H 20 0.06
Biotin 0.0072
Thiamine 0.0072
Pantothenic acid 0.0072
Trace elements 3 ml
The results of a typical laboratory batch production fermentation are shown in the accompanying Figure 2.
-1 -l
Some 15 g/l 1 cyclosophoran are produced with 15 g/l cells after 150 hours. Mannitol has been used as the carbon source, in order to facilitate identification of the product by glucose analysis. Other carbon sources, e.g. glucose, can be used, and that will obviously be more economic. In those circumstances, cyclosophorans can be detected by HPLC.
Cyclosophorans are very water-soluble. They may be precipitated with excess isopropanol. Because the fermentation broth has a low viscosity, the bacteria may be removed by centrifugation.
In a second, pilot plant run, the cells were removed by cross-flow microfiltration, and the product was concentrated by ultrafiltration to 113 girl , and dried by rotary evaporation. Using 1000 mol wt cut-off membranes, the ultrafiltration flux rate was 1 to 7 litrelm2 /h at 1.4 bar.
3.
The 0.05 m pilot plant run produced 5 kg of final product. Figure 1 charts the fermentation. The long lag phase is the result of the low (2%) inoculum size used for convenience in this run. Because the broth is not viscous, the oxygen transfer problems associated with high biopolymer concentrations are absent. It may be desirable to increase the product/cell ratio. For example, this might be achieved through fed-batch operation.
Cyclosophorans may be isolated, free from pigment, by filtration through a charcoal column. The cyclic glucans bind to the column and can be eluted separately with 30% ethanol. The collected material was evaporated to dryness and stored for analysis.
Neutral sugars present in the powdered material were released by a Saeman hydrolysis and analysed as alditol acetates by glc. Glucose was the only sugar detected.
Glycosidic linkages were determined as methylated alditol acetates by glc mass spectrometry. The only linkage detected was (1+2) linked glucose, indicating pure cyclosophoran. The distribution of ring sizes was investigated by fast atom bombardment mass spectrometry (FAB-MS): the spectrum indicated the presence of major components with ring sizes corresponding to dp = 17,18,19,20 and 21. This spectrum of ring sizes is characteristic of wild-type R. leguminosarum and has been dubbed a type II pattern (see Koizumi et al, supra).
Claims (7)
1. A process for preparing a cyclosophoran, which comprises cultivating a suitable mutant strain that has been prepared by introducing a transposon into the parent strain, the parent strain being capable of producing both cyclosophoran and extracellular polysaccharide while the mutant strain is incapable of producing extracellular polysaccharide.
2. A process according to claim 1, which comprises cultivating a microorganism having the characteristics of Rhizobium leguminosarum NCIMB 40260.
3. A microorganism capable of producing cyclosophoran but incapable of producing extracellular polysaccharide, being a mutant strain that has been prepared by introducing a transposon into a parent strain, the parent strain being capable of producing both cyclosophoran and extracellular polysaccharide.
4. A microorganism according to claim 3, being a mutant of a parent strain of the genus Agrobacterium or the genus Rhizobium.
5. Rhizobium leguminosarum NCIMB 40260.
6. A process according to claim 1, substantially as hereinbefore described with reference to the Example and the accompanying figures.
7. A cyclosophoran when prepared by a process according to any of claims 1, 2 or
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9005051A GB2241705B (en) | 1990-03-06 | 1990-03-06 | Preparing glucans |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9005051A GB2241705B (en) | 1990-03-06 | 1990-03-06 | Preparing glucans |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB9005051D0 GB9005051D0 (en) | 1990-05-02 |
| GB2241705A true GB2241705A (en) | 1991-09-11 |
| GB2241705B GB2241705B (en) | 1993-04-21 |
Family
ID=10672132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9005051A Expired - Fee Related GB2241705B (en) | 1990-03-06 | 1990-03-06 | Preparing glucans |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2241705B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107653276A (en) * | 2017-11-09 | 2018-02-02 | 江南大学 | A kind of dextran fermentation methods of ring β 1,2 for suppressing pigment and being formed |
-
1990
- 1990-03-06 GB GB9005051A patent/GB2241705B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107653276A (en) * | 2017-11-09 | 2018-02-02 | 江南大学 | A kind of dextran fermentation methods of ring β 1,2 for suppressing pigment and being formed |
| CN107653276B (en) * | 2017-11-09 | 2020-12-29 | 江南大学 | A kind of cyclic beta-1,2-glucan fermentation method for inhibiting pigment formation |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9005051D0 (en) | 1990-05-02 |
| GB2241705B (en) | 1993-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3751066T2 (en) | PRODUCTION PROCESS OF SUGAR NUCLEOTIDES BY MEANS OF A RECOMBINANT PROCESS. | |
| EP0077680B1 (en) | Heteropolysaccharide s-194, a process for producing it, and compositions containing it | |
| US4186025A (en) | Aqueous polysaccharide composition | |
| EP2360238B1 (en) | A yellow pigments generation deficient sphingomonas strain and its application in the production of gellan gum | |
| DE69031803T2 (en) | METHOD AND NUCLEIC ACID SEQUENCES FOR EXPRESSING THE CELLULOSE SYNTHASE OPERON | |
| DE69710744T2 (en) | METHOD FOR BIOTRANSFORMING COLCHICINOID COMPOUNDS IN THE CORRESPONDING 3-GLYCOSYL DERIVATIVES | |
| EP0300273B1 (en) | AB-006 antibiotics and process for their production | |
| GB2241705A (en) | Preparing glucans | |
| EP0091781A1 (en) | Improvement in lankacidins productions | |
| DE69420704T2 (en) | ALTEROMONA TYPE BACTERIA, POLYSACCHARIDES PRODUCED BY THESE BACTERIA, OSE CONTAINED IN THESE POLYSACCHARIDES AND THEIR APPLICATIONS | |
| US4950604A (en) | Culture of a microorgansim of the genus klebsiella sp., having a high content of rhamnose | |
| JPS61247396A (en) | Production of genisteine | |
| DE69218067T2 (en) | Process for the preparation of 3-deacylated derivatives of a 16-membered macrolide antibiotic, the microorganism used therefor, and new macrolide antibiotic | |
| US4940582A (en) | Antibiotic YI-HU3 | |
| EP0346831B1 (en) | Antibiotics and process for producing them | |
| EP0385361B1 (en) | A novel exo-type hydrolase and a method of manufacturing inulotriose and/or inulotetrose | |
| KR890002698B1 (en) | Heteropolysaccharide S-184 and preparation method thereof | |
| EP0413967B1 (en) | Novel antibiotic | |
| US4286059A (en) | Polysaccharide and bacterial fermentation process for its preparation | |
| Harris et al. | Characterisation of cyclosophorans produced by an acidic polysaccharide-negative mutant of Rhizobium leguminosaram | |
| JPS637757B2 (en) | ||
| CA2113871C (en) | A strain of streptomyces lavendofoliae dkrs and a method for producing aclacinomycins a,b,y and aglycones using the same | |
| CA1169795A (en) | Microbial process for producing cholanic acid derivatives and microbes used therein | |
| JPH0547560B2 (en) | ||
| JPH0370719B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19960306 |